Advertisement
U.S. markets open in 5 hours 5 minutes
  • S&P Futures

    5,143.50
    -2.50 (-0.05%)
     
  • Dow Futures

    39,076.00
    -66.00 (-0.17%)
     
  • Nasdaq Futures

    18,356.50
    +18.25 (+0.10%)
     
  • Russell 2000 Futures

    2,081.50
    +3.30 (+0.16%)
     
  • Crude Oil

    80.15
    +0.18 (+0.23%)
     
  • Gold

    2,092.50
    -3.20 (-0.15%)
     
  • Silver

    23.34
    -0.02 (-0.08%)
     
  • EUR/USD

    1.0848
    +0.0009 (+0.09%)
     
  • 10-Yr Bond

    4.1800
    0.0000 (0.00%)
     
  • Vix

    13.49
    +0.38 (+2.90%)
     
  • GBP/USD

    1.2671
    +0.0016 (+0.12%)
     
  • USD/JPY

    150.3270
    +0.2630 (+0.18%)
     
  • Bitcoin USD

    64,960.26
    +3,147.79 (+5.09%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,659.47
    -23.03 (-0.30%)
     
  • Nikkei 225

    40,109.23
    +198.41 (+0.50%)
     

Invitae Corp (NVTA) COO Kenneth D. Knight Sold $680,901 of Shares

- By insider

COO of Invitae Corp (30-Year Financial, Insider Trades) Kenneth D. Knight (insider trades) sold 13,351 shares of NVTA on 12/16/2020 at an average price of $51 a share. The total sale was $680,901.


Invitae Corp is a genetic information company engaged in genetic diagnostics for hereditary disorders. It provides testing for multiple genes including hereditary cancer, neurological disorders, cardiovascular disorders and other hereditary conditions. Invitae Corp has a market cap of $8.4 billion; its shares were traded at around $47.560000 with and P/S ratio of 21.61. GuruFocus has detected 1 severe warning sign with Invitae Corp. .

CEO Recent Trades:

  • President & CEO Sean E George sold 8,683 shares of NVTA stock on 11/20/2020 at the average price of $47.98. The price of the stock has decreased by 0.88% since.

Directors and Officers Recent Trades:

  • President, Oncology Jason W. Myers sold 253,912 shares of NVTA stock on 12/18/2020 at the average price of $47.49. The price of the stock has increased by 0.15% since.

  • Director Eric Aguiar sold 10,000 shares of NVTA stock on 12/16/2020 at the average price of $51. The price of the stock has decreased by 6.75% since.

  • COO Kenneth D. Knight sold 13,351 shares of NVTA stock on 12/16/2020 at the average price of $51. The price of the stock has decreased by 6.75% since.

  • Chief Commercial Officer Katherine Stueland sold 34,300 shares of NVTA stock on 12/14/2020 at the average price of $58.43. The price of the stock has decreased by 18.6% since.

  • Chief Accounting Officer Robert F. Werner sold 2,427 shares of NVTA stock on 11/24/2020 at the average price of $48.92. The price of the stock has decreased by 2.78% since.

For the complete insider trading history of NVTA, click here

.This article first appeared on GuruFocus.

Advertisement